MYGN logo

Myriad Genetics (MYGN) Revenue

Annual Revenue

$753.20 M
+$74.80 M+11.03%

December 1, 2023

Summary

Performance

1-Year Change

+11.03%

3-Year Change

+151.23%

5-Year Change

-11.5%

15-Year Change

+3.36%

MYGN Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

78.56%
MYGN annual revenue is higher than 78.56% of companies in Healthcare sector

Analysts Estimate

$837.40 M
MYGN annual revenue is currently -10.05% lower than the consensus analysts' forecast

High & Low

All-time High

$851.10 M
MYGN annual revenue is currently -11.50% below its historical high of $851.10 million

3-Year Low

$678.40 M
MYGN annual revenue is currently +11.03% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
MYGN previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

Feb 27, 2025
MYGN next annual earnings announcement is scheduled for Feb 27, 2025

OtherMYGNprofitabilitymetrics:

Annual EPS

-$3.18
MYGN annual earnings per share is -$3.18

Annual Net Income

-$263.30 M
MYGN annual net profit is -$263.30 million

Annual Operating Profit

-$144.60 M
MYGN annual operating income is -$144.60 million

Annual Gross Profit

$517.00 M
MYGN annual gross profit is $517.00 million

Quarterly Revenue

$213.30 M
+$1.80 M+0.85%

September 1, 2024

Summary

Performance

3-Month Change

+0.85%

1-Year Change

+5.49%

3-Year Change

+19.97%

5-Year Change

+9.33%

MYGN Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

77.25%
MYGN quarterly revenue is higher than 77.25% of companies in Healthcare sector

Analysts Estimate

$210.40 M
MYGN quarterly revenue is currently +1.38% higher than the consensus analysts' forecast

High & Low

All-time High

$216.80 M
MYGN quarterly revenue is currently -1.61% below its historical high of $216.80 million

3-Year Low

$156.40 M
MYGN quarterly revenue is currently +36.38% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
MYGN previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Feb 27, 2025
MYGN next earnings announcement is scheduled for Feb 27, 2025

Related metrics

Quarterly Gross Profit

$149.80 M
MYGN quarterly gross profit is $149.80 million

Quarterly Operating Profit

-$17.80 M
MYGN quarterly operating income is -$17.80 million

Quarterly Net Income

-$22.10 M
MYGN quarterly net profit is -$22.10 million

Quarterly EPS

-$0.24
MYGN quarterly earnings per share is -$0.24

TTM Revenue

$823.60 M
+$21.40 M+2.67%

September 1, 2024

Summary

Performance

3-Month Change

+2.67%

1-Year Change

+6.38%

3-Year Change

+21.4%

5-Year Change

+1.25%

MYGN TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

76.75%
MYGN TTM revenue is higher than 76.75% of companies in Healthcare sector

Analysts Estimate

$837.40 M
MYGN TTM revenue is currently -1.65% lower than the consensus analysts' forecast

High & Low

All-time High

$851.10 M
MYGN TTM revenue is currently -3.23% below its historical high of $851.10 million

3-Year Low

$661.40 M
MYGN TTM revenue is currently +24.52% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
MYGN previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Feb 27, 2025
MYGN next earnings announcement is scheduled for Feb 27, 2025

OtherMYGNprofitabilitymetrics:

TTM Gross Profit

$569.50 M
MYGN TTM gross profit is $569.50 million

TTM Operating Profit

-$101.00 M
MYGN TTM operating income is -$101.00 million

TTM Net Income

-$116.00 M
MYGN TTM net profit is -$116.00 million

TTM EPS

-$1.30
MYGN TTM earnings per share is -$1.30

MYGN Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+11.0%+5.5%+6.4%
3 y3 years+151.2%+20.0%+21.4%
5 y5 years-11.5%+9.3%+1.3%

MYGN Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+11.0%at high+36.4%at high+24.5%
5 y5-year-11.5%+151.2%at high+128.9%at high+100.2%
alltimeall time-11.5%>+9999.0%-1.6%>+9999.0%-3.2%>+9999.0%

Myriad Genetics Revenue History

DateAnnualQuarterlyTTM
Sep 2024
-
$213.30 M(+0.9%)
$823.60 M(+2.7%)
Jun 2024
-
$211.50 M(+4.6%)
$802.20 M(+3.6%)
Mar 2024
-
$202.20 M(+2.8%)
$774.20 M(+2.8%)
Dec 2023
$753.20 M(+11.0%)
$196.60 M(+2.4%)
$753.20 M(+2.6%)
Sep 2023
-
$191.90 M(+4.6%)
$734.40 M(+5.1%)
Jun 2023
-
$183.50 M(+1.3%)
$698.90 M(+0.6%)
Mar 2023
-
$181.20 M(+1.9%)
$694.70 M(+2.4%)
Dec 2022
$678.40 M(-1.8%)
$177.80 M(+13.7%)
$678.40 M(+2.6%)
Sep 2022
-
$156.40 M(-12.8%)
$661.40 M(-1.6%)
Jun 2022
-
$179.30 M(+8.7%)
$672.30 M(-1.5%)
Mar 2022
-
$164.90 M(+2.5%)
$682.40 M(-1.2%)
Dec 2021
$690.60 M(+130.4%)
$160.80 M(-3.9%)
$690.60 M(+30.4%)
Sep 2021
-
$167.30 M(-11.7%)
$529.80 M(+4.4%)
Jun 2021
-
$189.40 M(+9.4%)
$507.70 M(+23.4%)
Mar 2021
-
$173.10 M(+19.2%)
$411.50 M(-31.1%)
Dec 2020
$299.80 M(-53.1%)
-
-
Sep 2020
-
$145.20 M(+55.8%)
$597.50 M(-6.4%)
Jun 2020
$638.60 M(-25.0%)
$93.20 M(-43.2%)
$638.60 M(-16.1%)
Mar 2020
-
$164.00 M(-15.9%)
$760.80 M(-6.5%)
Dec 2019
-
$195.10 M(+4.7%)
$813.40 M(-2.6%)
Sep 2019
-
$186.30 M(-13.5%)
$835.10 M(-1.9%)
Jun 2019
$851.10 M(+14.4%)
$215.40 M(-0.6%)
$851.10 M(+2.6%)
Mar 2019
-
$216.60 M(-0.1%)
$829.60 M(+4.2%)
Dec 2018
-
$216.80 M(+7.2%)
$796.10 M(+3.8%)
Sep 2018
-
$202.30 M(+4.3%)
$767.20 M(+3.2%)
Jun 2018
$743.70 M(+2.1%)
$193.90 M(+5.9%)
$743.70 M(+5.1%)
Mar 2018
-
$183.10 M(-2.6%)
$707.60 M(-1.9%)
Dec 2017
-
$187.90 M(+5.1%)
$721.40 M(-1.2%)
Sep 2017
-
$178.80 M(+13.3%)
$730.00 M(+0.2%)
Jun 2017
$728.70 M(-1.6%)
$157.80 M(-19.9%)
$728.70 M(-2.1%)
Mar 2017
-
$196.90 M(+0.2%)
$744.00 M(+0.9%)
Dec 2016
-
$196.50 M(+10.7%)
$737.60 M(+0.4%)
Sep 2016
-
$177.50 M(+2.5%)
$734.40 M(-0.8%)
Jun 2016
$740.50 M(+2.4%)
$173.10 M(-9.1%)
$740.40 M(-2.2%)
Mar 2016
-
$190.50 M(-1.4%)
$757.20 M(+1.4%)
Dec 2015
-
$193.30 M(+5.3%)
$746.70 M(+1.2%)
Sep 2015
-
$183.50 M(-3.4%)
$737.80 M(+2.0%)
Jun 2015
$723.10 M(-7.1%)
$189.90 M(+5.5%)
$723.10 M(+0.2%)
Mar 2015
-
$180.00 M(-2.4%)
$721.95 M(-0.4%)
Dec 2014
-
$184.40 M(+9.2%)
$724.87 M(-2.6%)
Sep 2014
-
$168.80 M(-10.6%)
$744.53 M(-4.3%)
Jun 2014
$778.20 M(+26.9%)
$188.75 M(+3.2%)
$778.20 M(+1.9%)
Mar 2014
-
$182.92 M(-10.4%)
$763.60 M(+3.6%)
Dec 2013
-
$204.06 M(+0.8%)
$737.15 M(+8.1%)
Sep 2013
-
$202.47 M(+16.3%)
$682.23 M(+11.3%)
Jun 2013
$613.20 M(+23.6%)
$174.15 M(+11.3%)
$613.20 M(+7.2%)
Mar 2013
-
$156.47 M(+4.9%)
$572.01 M(+4.9%)
Dec 2012
-
$149.14 M(+11.8%)
$545.32 M(+5.1%)
Sep 2012
-
$133.44 M(+0.4%)
$518.99 M(+4.6%)
Jun 2012
$496.00 M(+23.4%)
$132.97 M(+2.5%)
$496.00 M(+5.4%)
Mar 2012
-
$129.78 M(+5.7%)
$470.45 M(+6.2%)
Dec 2011
-
$122.81 M(+11.2%)
$443.05 M(+5.3%)
Sep 2011
-
$110.45 M(+2.8%)
$420.68 M(+4.6%)
Jun 2011
$402.08 M(+10.9%)
$107.41 M(+4.9%)
$402.08 M(+3.5%)
Mar 2011
-
$102.37 M(+1.9%)
$388.60 M(+3.1%)
Dec 2010
-
$100.44 M(+9.3%)
$377.06 M(+2.1%)
Sep 2010
-
$91.86 M(-2.2%)
$369.38 M(+1.9%)
Jun 2010
$362.65 M
$93.93 M(+3.4%)
$362.65 M(+2.2%)
DateAnnualQuarterlyTTM
Mar 2010
-
$90.83 M(-2.1%)
$354.80 M(+1.2%)
Dec 2009
-
$92.77 M(+9.0%)
$350.50 M(+2.6%)
Sep 2009
-
$85.12 M(-1.1%)
$341.68 M(+3.5%)
Jun 2009
$326.53 M(+46.5%)
$86.08 M(-0.5%)
$330.21 M(+10.0%)
Mar 2009
-
$86.53 M(+3.1%)
$300.21 M(+9.0%)
Dec 2008
-
$83.95 M(+14.0%)
$275.45 M(+11.0%)
Sep 2008
-
$73.65 M(+31.3%)
$248.24 M(+11.4%)
Jun 2008
$222.85 M(+41.8%)
$56.08 M(-9.2%)
$222.85 M(+5.0%)
Mar 2008
-
$61.77 M(+8.9%)
$212.25 M(+10.9%)
Dec 2007
-
$56.74 M(+17.6%)
$191.46 M(+11.4%)
Sep 2007
-
$48.27 M(+6.1%)
$171.85 M(+9.4%)
Jun 2007
$157.13 M(+37.5%)
$45.48 M(+11.0%)
$157.13 M(+9.4%)
Mar 2007
-
$40.97 M(+10.3%)
$143.67 M(+8.4%)
Dec 2006
-
$37.13 M(+10.7%)
$132.51 M(+8.0%)
Sep 2006
-
$33.54 M(+4.7%)
$122.71 M(+7.4%)
Jun 2006
$114.28 M(+38.7%)
$32.02 M(+7.4%)
$114.28 M(+5.5%)
Mar 2006
-
$29.81 M(+9.1%)
$108.35 M(+10.0%)
Dec 2005
-
$27.33 M(+8.8%)
$98.50 M(+8.5%)
Sep 2005
-
$25.11 M(-3.8%)
$90.81 M(+10.2%)
Jun 2005
$82.41 M(+45.5%)
$26.10 M(+30.7%)
$82.41 M(+15.4%)
Mar 2005
-
$19.96 M(+1.6%)
$71.38 M(+9.5%)
Dec 2004
-
$19.64 M(+17.5%)
$65.18 M(+9.2%)
Sep 2004
-
$16.71 M(+10.9%)
$59.69 M(+5.4%)
Jun 2004
$56.65 M(-11.9%)
$15.07 M(+9.6%)
$56.65 M(-1.1%)
Mar 2004
-
$13.76 M(-2.8%)
$57.28 M(-3.9%)
Dec 2003
-
$14.15 M(+3.5%)
$59.61 M(-4.6%)
Sep 2003
-
$13.67 M(-12.9%)
$62.48 M(-2.9%)
Jun 2003
$64.32 M(+19.5%)
$15.70 M(-2.4%)
$64.32 M(+2.5%)
Mar 2003
-
$16.09 M(-5.5%)
$62.73 M(+5.1%)
Dec 2002
-
$17.02 M(+9.7%)
$59.70 M(+6.3%)
Sep 2002
-
$15.51 M(+9.9%)
$56.16 M(+4.3%)
Jun 2002
$53.84 M(+19.2%)
$14.11 M(+8.1%)
$53.84 M(+6.5%)
Mar 2002
-
$13.06 M(-3.1%)
$50.55 M(+3.0%)
Dec 2001
-
$13.48 M(+2.2%)
$49.05 M(+3.2%)
Sep 2001
-
$13.19 M(+21.9%)
$47.53 M(+5.2%)
Jun 2001
$45.16 M(+32.8%)
$10.82 M(-6.4%)
$45.16 M(+3.8%)
Mar 2001
-
$11.57 M(-3.2%)
$43.50 M(+4.4%)
Dec 2000
-
$11.95 M(+10.5%)
$41.65 M(+9.6%)
Sep 2000
-
$10.82 M(+18.2%)
$37.99 M(+11.5%)
Jun 2000
$34.01 M(+34.4%)
$9.16 M(-5.7%)
$34.07 M(+7.0%)
Mar 2000
-
$9.71 M(+17.0%)
$31.85 M(+9.1%)
Dec 1999
-
$8.30 M(+20.3%)
$29.19 M(+9.8%)
Sep 1999
-
$6.90 M(-0.4%)
$26.59 M(+5.1%)
Jun 1999
$25.30 M(+9.1%)
$6.93 M(-1.9%)
$25.29 M(+1.7%)
Mar 1999
-
$7.06 M(+23.9%)
$24.86 M(+5.8%)
Dec 1998
-
$5.70 M(+1.8%)
$23.50 M(+2.6%)
Sep 1998
-
$5.60 M(-13.8%)
$22.90 M(-1.3%)
Jun 1998
$23.20 M(+52.6%)
$6.50 M(+14.0%)
$23.20 M(-4.1%)
Mar 1998
-
$5.70 M(+11.8%)
$24.20 M(+14.2%)
Dec 1997
-
$5.10 M(-13.6%)
$21.20 M(+12.2%)
Sep 1997
-
$5.90 M(-21.3%)
$18.90 M(+24.3%)
Jun 1997
$15.20 M(+130.3%)
$7.50 M(+177.8%)
$15.20 M(+56.7%)
Mar 1997
-
$2.70 M(-3.6%)
$9.70 M(+9.0%)
Dec 1996
-
$2.80 M(+27.3%)
$8.90 M(+14.1%)
Sep 1996
-
$2.20 M(+10.0%)
$7.80 M(+18.2%)
Jun 1996
$6.60 M
$2.00 M(+5.3%)
$6.60 M(+43.5%)
Mar 1996
-
$1.90 M(+11.8%)
$4.60 M(+70.4%)
Dec 1995
-
$1.70 M(+70.0%)
$2.70 M(+170.0%)
Sep 1995
-
$1.00 M
$1.00 M

FAQ

  • What is Myriad Genetics annual revenue?
  • What is the all time high annual revenue for Myriad Genetics?
  • What is Myriad Genetics annual revenue year-on-year change?
  • What is Myriad Genetics quarterly revenue?
  • What is the all time high quarterly revenue for Myriad Genetics?
  • What is Myriad Genetics quarterly revenue year-on-year change?
  • What is Myriad Genetics TTM revenue?
  • What is the all time high TTM revenue for Myriad Genetics?
  • What is Myriad Genetics TTM revenue year-on-year change?

What is Myriad Genetics annual revenue?

The current annual revenue of MYGN is $753.20 M

What is the all time high annual revenue for Myriad Genetics?

Myriad Genetics all-time high annual revenue is $851.10 M

What is Myriad Genetics annual revenue year-on-year change?

Over the past year, MYGN annual revenue has changed by +$74.80 M (+11.03%)

What is Myriad Genetics quarterly revenue?

The current quarterly revenue of MYGN is $213.30 M

What is the all time high quarterly revenue for Myriad Genetics?

Myriad Genetics all-time high quarterly revenue is $216.80 M

What is Myriad Genetics quarterly revenue year-on-year change?

Over the past year, MYGN quarterly revenue has changed by +$11.10 M (+5.49%)

What is Myriad Genetics TTM revenue?

The current TTM revenue of MYGN is $823.60 M

What is the all time high TTM revenue for Myriad Genetics?

Myriad Genetics all-time high TTM revenue is $851.10 M

What is Myriad Genetics TTM revenue year-on-year change?

Over the past year, MYGN TTM revenue has changed by +$49.40 M (+6.38%)